Approval · Notice of Compliance 20394 · 2018
ACTOS: Notice of Compliance 20394
Issued January 19, 2018
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 20394
- Date
- January 19, 2018
- Company
- Takeda Canada IncorporatedToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to the product monograph with sagety information regarding bladder cancer
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ACTOS | Not yet assigned | — |
Medicinal ingredients
- PIOGLITAZONE HYDROCHLORIDE 15 MG per TAB
- PIOGLITAZONE HYDROCHLORIDE 30 MG per TAB
- PIOGLITAZONE HYDROCHLORIDE 45 MG per TAB